Yaman Eksioglu, MD
Neurology with Special Qualifications in Child Neurology · Lexington, MANPI 1326071911
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Eisai CO., LTD. at 54.7% of the total. Reporting peaked in 2021 at $2,400 and has fallen 86.7% since, to $319 in 2025.
Across 18 payments — averaging $243.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai CO., LTD.$2K
- Monteris Medical Corporation$1K
- Greenwich Biosciences, Inc.$296
- Biomarin Pharmaceutical Inc.$265
- SK Life Science, Inc.$128
- Neuropace, Inc.$57
- plus $124 from 5 others
What the payments were for
- Consulting fees$2,40055%
- Travel & lodging$78818%
- Food & beverage$1,20127%
- Education$10%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai CO., LTD. | 1 | $2,400 |
| Monteris Medical Corporation | 7 | $1,120 |
| Greenwich Biosciences, Inc. | 1 | $296 |
| Biomarin Pharmaceutical Inc. | 2 | $265 |
| SK Life Science, Inc. | 1 | $128 |
| Neuropace, Inc. | 1 | $57 |
| Zimmer Biomet | 1 | $57 |
| UCB, Inc. | 1 | $26 |
| Sunovion Pharmaceuticals Inc. | 1 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Travere Therapeutics, Inc. | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Fycompa$2,400
- Neuroblate$922
- Epidiolex$296
- Palynziq$176
How this compares
$4,390 in reported general payments places this provider in the 80th percentile of 101 neurology with special qualifications in child neurology providers in Massachusetts.
See all neurology with special qualifications in child neurology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology with special qualifications in child neurology in Lexington
- Elizabeth ThieleBoston$278K
- Jurriaan PetersBoston$265K
- Basil DarrasBoston$253K
- Kiran MaskiBoston$105K
- Phillip PearlBoston$50K
- Paul ChervinWoburn$36K
- Alexander RotenbergBoston$34K
- Irina AnselmBoston$30K
- Nicole UllrichBoston$26K
- David LiebermanBoston$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.